543P Entrectinib in NTRK fusion-positive NSCLC: Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001

Authors :: Christian D. Rolfo
A. Drilon
Lyudmilla Bazhenova
John C. Krauss
Juergen Wolf
Anna F. Farago
D. Tosi
Shanta Chawla
Takashi Seto
Benjamin Besse
Collin M. Blakely
George D. Demetri
Byoung Chul Cho
A. Aziez
S. Osborne
Thomas John
Luis Paz-Ares
Stephen V. Liu
Robert C. Doebele
Source :: Annals of Oncology. 31:S474-S475
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
business.industry
Cancer research
Medicine
Entrectinib
Hematology
business

Full Text Access

Tools